Elekta (STO:EKTA B) today announced that it received FDA 510(k) premarket notification for its diffusion-weighted MR images from the Elekta Unity. The clearance allows the images to be interpreted by a trained physician. With the new FDA clearance, the system can be used for the biologic assessment of tumor response during therapy. Diffusion-weighted MR images (DWI) […]
Elekta
Elekta buys treatment planner ProKnow Systems
Elekta (STO:EKTA B) said today that it acquired ProKnow Systems for an undisclosed amount in a move toward cloud-based solutions for advanced radiation therapy. Sweden-based Elekta will have access to ProKnow’s products, namely the ProKnow DS, to offer the cloud-based analytics systems and standardize its practices. The ProKnow DS is designed to allow for analysis of […]
Elekta files patent suit against Zap Surgical
Surgical system maker Zap Surgical Systems said yesterday that it is facing a patent infringement lawsuit from Elekta (STO:EKTA B) related to its Zap-X gyroscopic radiosurgery platform. San Carlos, Calif.-based Zap Surgical said that said that it is facing a lawsuit in the U.S. District Court for the Northern District of California asserting that its Zap-X […]
Elekta wins Health Canada approval for Elekta Unity MR radiation therapy system
Elekta (STO:EKTA B) said today that it won Health Canada approval for its Elekta Unity magnetic resonance radiation therapy system. The Elekta Unity system consists of a high-field 1.5 Tesla MRI scanner and a linear accelerator alongside integrated real-time dose planning software for target monitoring, the Stockholm-based company said. Elekta added that its Elekta Unity device […]
Elekta picks up radiology QA software dev Acumyn
Elekta (STO:EKTA B) said late last week it acquired Canadian quality assurance company Acumyn for an undisclosed amount. Acumyn, which spun-out of Toronto’s University Hospital Network, was started to commercialize the Aqua software platform. Aqua is intended to coordinate, centralize and automate all QA tests that need to be performed in radiotherapy clinics, Elekta said. “This […]
York Instruments picks up Elekta’s MEG biz
Croton Healthcare subsidiary York Instruments said today that it’s buying the magnetoencephalography business at Elekta (STO:EKTA B) for an undisclosed amount. The MEG technology is designed to map brain activity in clinical and research settings. Elekta’s MEGIN business put up sales of about $11.6 million last year (SEK102 million). Get the full story at our sister site, Medical […]
Elekta wins CE Mark for Unity high-field MR-linac
Elekta (STO:EKTA B) said today it won CE Mark approval in the European Union for its Elekta Unity magnetic resonance radiation therapy system. The Stockholm-based company touted that its Unity system allows clinicians to deliver radiation doses while simultaneously visualizing the tumor and surrounding tissue through MR imaging. The system also features integrated advanced tools […]
Brainlab releases VersaHD high-res planning algorithm
Brainlab said today it launched a new high-res planning algorithm within its Brainlab Elements software to improve radiation dose conformity for treating brain tumors, and added that the algorithm is a result of its strategic collaboration Elekta (STO:EKTA B). The Munich-based company’s Elements system operates with Elekta’s Agility multileaf collimator to compensate for the width of […]
Zimmer Biomet picks ex-Covidien exec Lannum for IR chief | Personnel Moves – March 20, 2018
Zimmer Biomet (NYSE:ZBH) said yesterday it tapped former Covidien investor relations head Coleman Lannum as its investor relations senior VP, reporting directly to prez & CEO Bryan Hanson. Lannum has more than 15 years in investor relations, having held positions with Mallinckrodt Pharmaceuticals (NYSE:MNK), Covidien and Tyco Healthcare. During his time with Covidien, Lannum oversaw the company’s initial […]
Elekta inks oncology co-selling deal with IBM Watson Health
Elekta (STO:EKTA B) said today it inked a collaborative sales deal with IBM‘s (NYSE:IBM) Watson Health through which Elekta will offer IBM’s Watson for Oncology with its cancer care solutions. With the deal, Elekta said it will begin offering the Watson for Oncology early this year as a clinical decision support solution paired with its digital cancer […]
Elekta taps Brainlab as US stereotactic neurosurgery distro partner
Elekta (STO:EKTA B) said today it inked an exclusive deal with Brainlab to make it the authorized distributor of Elekta’s stereotactic neurosurgery solutions. Through the deal, Brainlab will be the authorized distributor of Elekta’s Leksell Vantage stereotactic system which won CE Mark approval in the European Union this year. The system also has FDA 510(k) clearance […]
